# ITRMF (Iterum Therapeutics plc) - SEC EDGAR Financial Statements

> Iterum Therapeutics plc reported $32.50M in total assets and a net loss of $26.96M through December 31, 2024 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ITRMF
- Markdown: https://convexityos.com/fundamentals/ITRMF.md
- SEC CIK: 0001659323
- Reporting currency: USD
- Latest filing period: September 30, 2025
- Last synced: Nov 21, 2026, 05:11 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001659323&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2024 | -- | Dec 31, 2024 |
| Operating Income | FY 2024 | -$20.64M | Operating profit |
| Net Income | FY 2024 | -$26.96M | GAAP bottom line |
| Diluted EPS | FY 2024 | -$0.59 | Split-adjusted |
| Free Cash Flow | FY 2024 | -$26.77M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2025 | $11.00M | Total debt: $20.05M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | $0 | $0 | $37K | $869K | $508K | $0 |
| Research & Development | $10.46M | $39.99M | $17.62M | $10.71M | $21.07M | $90.77M | $68.65M | $25.50M | $10.10M |
| Total Operating Expenses | $18.70M | $47.47M | $30.38M | $24.54M | $32.13M | $102.1M | $77.43M | $29.96M | $13.36M |
| **Operating Income** | -$18.70M | -$47.47M | -$30.38M | -$24.54M | -$32.13M | -$102.0M | -$76.56M | -$29.45M | -$13.36M |
| **EBITDA** | -$18.41M | -$45.72M | -$28.58M | -$22.43M | -$31.96M | -$101.9M | -$76.42M | -$29.39M | -$13.36M |
| Interest Income | $789K | $1.72M | $819K | -- | -- | -- | -- | -- | -- |
| Interest Expense | $3.31M | $3.15M | $3.18M | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$24.53M | -$37.76M | -$44.13M | -$90.86M | -$51.26M | -$102.7M | -$76.58M | -$28.96M | -$13.35M |
| Income Tax Expense | $240K | $613K | $301K | $705K | $743K | $444K | $472K | $444K | $113K |
| **Net Income** | -$24.77M | -$38.37M | -$44.43M | -$91.56M | -$52.01M | -$103.1M | -$77.06M | -$29.41M | -$13.46M |
| Basic EPS | -$1.26 | -$2.96 | -$3.63 | -$8.41 | -$32.49 | -$106.50 | -$132.30 | -$2,562.60 | -$8,533.05 |
| **Diluted EPS** | -$1.26 | -$2.96 | -$3.63 | -$8.41 | -$32.49 | -$106.50 | -$132.30 | -$2,562.60 | -$8,533.05 |
| Basic Shares Outstanding | 19.7M | 13.0M | 12.2M | 10.9M | 1.6M | 967.9K | 582.3K | 11.5K | 1.6K |
| Diluted Shares Outstanding | 19.7M | 13.0M | 12.2M | 10.9M | 1.6M | 967.9K | 582.3K | 11.5K | 1.6K |

### Income Statement (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $390K | -- | -- | -- | -- | -- | -- | -- |
| Research & Development | $1.26M | $1.00M | $591K | $1.30M | $3.11M | $2.08M | $3.98M | $9.74M |
| Selling, General & Admin | $6.49M | -- | -- | -- | $1.78M | -- | -- | -- |
| Total Operating Expenses | $8.12M | $5.53M | $3.71M | $3.67M | $4.89M | $3.98M | $6.16M | $11.43M |
| **Operating Income** | -$7.73M | -$5.53M | -$3.71M | -$3.67M | -$4.89M | -$3.98M | -$6.16M | -$11.43M |
| **EBITDA** | -$7.38M | -$5.18M | -$3.36M | -$3.41M | -$4.88M | -$3.97M | -$6.16M | -$10.99M |
| Interest Income | $121K | $133K | $152K | $182K | $166K | $179K | $262K | -- |
| Interest Expense | $562K | $449K | $686K | $1.06M | $756K | $750K | $749K | -- |
| Income Before Tax | -$8.85M | -$6.45M | -$4.83M | -$6.56M | -$5.96M | -$4.97M | -$7.05M | -$12.22M |
| Income Tax Expense | $132K | $59K | $60K | $25K | $136K | $31K | $48K | $142K |
| **Net Income** | -$8.98M | -$6.51M | -$4.89M | -$6.58M | -$6.09M | -$5.00M | -$7.10M | -$12.36M |
| Basic EPS | -$0.20 | -$0.16 | -$0.14 | -- | -$0.30 | -$0.30 | -$0.46 | -- |
| **Diluted EPS** | -$0.20 | -$0.16 | -$0.14 | -- | -$0.30 | -$0.30 | -$0.46 | -- |
| Basic Shares Outstanding | 45.8M | 39.9M | 34.1M | -- | 20.0M | 16.6M | 15.4M | -- |
| Diluted Shares Outstanding | 45.8M | 39.9M | 34.1M | -- | 20.0M | 16.6M | 15.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $24.12M | $6.07M | $21.09M | $27.45M | $14.51M | $4.80M | $44.55M | $8.48M |
| Short-Term Investments | $0 | $17.86M | $39.71M | $53.90M | $0 | $0 | $40.00M | $30.73M |
| **Cash & Short-Term Investments** | $24.12M | $23.93M | $60.80M | $81.34M | $14.51M | $4.80M | $84.55M | $39.22M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Current Assets** | $24.79M | $25.60M | $62.44M | $83.27M | $21.47M | $11.72M | $92.97M | $44.17M |
| Property, Plant & Equipment, Net | $23K | $51K | $69K | $91K | $421K | $572K | $700K | $747K |
| Intangible Assets | $19.75M | -- | $1.72M | $3.44M | -- | -- | -- | -- |
| Other Non-Current Assets | $5.0K | $578K | $2.57M | $4.65M | $10.65M | $13.40M | $4.11M | $1.84M |
| **Total Non-Current Assets** | $19.81M | $663K | $4.39M | $8.24M | $11.32M | $14.03M | $4.90M | $2.58M |
| **Total Assets** | $44.59M | $26.26M | $66.83M | $91.51M | $32.79M | $25.75M | $97.87M | $46.76M |
| Accounts Payable | $251K | $5.00M | $2.77M | $878K | $816K | $15.49M | $4.04M | $3.15M |
| Short-Term Debt | -- | -- | -- | $1.63M | $6.37M | $5.80M | $1.02M | -- |
| Other Current Liabilities | $240K | $761K | $1.75M | $2.99M | $3.60M | $3.04M | -- | -- |
| **Total Current Liabilities** | $17.61M | $13.52M | $9.06M | $12.94M | $41.70M | $36.99M | $12.22M | $7.13M |
| Long-Term Debt | $31.22M | $11.45M | $10.09M | $6.93M | $22.46M | $7.62M | $13.08M | $0 |
| Other Non-Current Liabilities | $0 | $188K | $1.30M | $3.44M | $5.80M | $7.38M | $951K | $80K |
| **Total Non-Current Liabilities** | $31.07M | $19.14M | $29.77M | $28.33M | $41.65M | $15.00M | $14.03M | $80K |
| **Total Liabilities** | $48.68M | $32.66M | $38.83M | $41.27M | $83.35M | $51.99M | $26.25M | $7.21M |
| **Total Debt (incl. Leases)** | $31.29M | $12.01M | $11.73M | $12.46M | $34.58M | $20.75M | $14.10M | $0 |
| Common Stock | $315K | $135K | $126K | $122K | $494K | $149K | $144K | $4.0K |
| Retained Earnings | -$486.1M | -$461.3M | -$422.9M | -$378.5M | -$286.9M | -$234.9M | -$131.8M | -$54.74M |
| Accumulated Other Comp. Income | $0 | $1.0K | -$350K | -- | -- | -- | -- | -- |
| **Total Stockholders' Equity** | -$4.08M | -$6.40M | $28.00M | $50.23M | -$50.56M | -$26.24M | $71.62M | $39.49M |
| Total Equity | -$4.08M | -$6.40M | $28.00M | $50.23M | -$50.56M | -$26.24M | $71.62M | $39.49M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $11.00M | $13.03M | $12.65M | $24.12M | $13.41M | $4.98M | $7.39M | $6.07M |
| Short-Term Investments | -- | -- | -- | $0 | $1.10M | $6.74M | $10.82M | $17.86M |
| **Cash & Short-Term Investments** | $11.00M | $13.03M | $12.65M | $24.12M | $14.50M | $11.72M | $18.21M | $23.93M |
| Accounts Receivable, Net | $448K | -- | -- | -- | -- | -- | -- | -- |
| Inventory | $1.15M | $948K | $533K | $0 | -- | -- | -- | $0 |
| **Total Current Assets** | $13.73M | $14.89M | $13.51M | $24.79M | $15.85M | $13.70M | $19.05M | $25.60M |
| Property, Plant & Equipment, Net | $18K | $12K | $18K | $23K | $30K | $38K | $44K | $51K |
| Intangible Assets | $18.71M | $19.06M | $19.40M | $19.75M | -- | -- | -- | -- |
| Other Non-Current Assets | $19K | $19K | $6.0K | $5.0K | $6.0K | $407K | $493K | $578K |
| **Total Non-Current Assets** | $18.78M | $19.12M | $19.46M | $19.81M | $70K | $479K | $571K | $663K |
| **Total Assets** | $32.50M | $34.01M | $32.98M | $44.59M | $15.92M | $14.17M | $19.62M | $26.26M |
| Accounts Payable | $577K | $1.19M | $413K | $251K | $835K | $822K | $2.97M | $5.00M |
| Other Current Liabilities | $332K | $197K | $201K | $240K | $668K | $741K | $755K | $761K |
| **Total Current Liabilities** | $6.43M | $5.53M | $3.63M | $17.61M | $18.70M | $16.77M | $17.79M | $13.52M |
| Long-Term Debt | $20.05M | $20.10M | $20.10M | $31.22M | $11.22M | $11.22M | $11.22M | $11.45M |
| Other Non-Current Liabilities | -- | -- | -- | $0 | -- | $16K | $92K | $188K |
| **Total Non-Current Liabilities** | $33.45M | $32.37M | $31.90M | $31.07M | $8.73M | $8.31M | $7.98M | $19.14M |
| **Total Liabilities** | $39.88M | $37.90M | $35.53M | $48.68M | $27.43M | $25.09M | $25.77M | $32.66M |
| **Total Debt (incl. Leases)** | $20.05M | $20.10M | $20.12M | $31.29M | $11.49M | $11.59M | $11.68M | $12.01M |
| Common Stock | $490K | $421K | $357K | $315K | $227K | $166K | $165K | $135K |
| Retained Earnings | -$506.5M | -$497.5M | -$491.0M | -$486.1M | -$479.5M | -$473.4M | -$468.4M | -$461.3M |
| Accumulated Other Comp. Income | -- | $0 | $0 | $0 | $2.0K | -$1.0K | -- | $1.0K |
| **Total Stockholders' Equity** | -$7.38M | -$3.89M | -$2.55M | -$4.08M | -$11.51M | -$10.91M | -$6.15M | -$6.40M |
| Total Equity | -$7.38M | -$3.89M | -$2.55M | -$4.08M | -$11.51M | -$10.91M | -$6.15M | -$6.40M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$24.77M | -$38.37M | -$44.43M | -$91.56M | -$52.01M | -$103.1M | -$77.06M | -$29.41M | -$13.46M |
| Depreciation & Amortization | $284K | $1.75M | $1.80M | $2.10M | $161K | $152K | $136K | $65K | $0 |
| Stock-Based Compensation | $363K | $784K | $4.76M | $4.32M | $2.76M | $2.17M | $1.29M | $392K | $348K |
| Change in Payables | -$4.75M | $2.22M | $1.90M | $63K | -$14.67M | $11.45M | $849K | $1.67M | $1.19M |
| **Operating Cash Flow** | -$26.77M | -$39.33M | -$18.47M | -$15.84M | -$54.53M | -$81.92M | -$77.25M | -$30.60M | -$11.30M |
| Capital Expenditure | -$2.0K | -$13K | -$62K | -$61K | -$11K | -$24K | -$90K | -$812K | -- |
| **Free Cash Flow** | -$26.77M | -$39.34M | -$18.54M | -$15.90M | -$54.54M | -$81.95M | -$77.34M | -$31.42M | -- |
| Purchases of Investments | -$12.39M | -$41.18M | -$45.71M | -$67.03M | -- | -- | -$96.49M | -$53.27M | -- |
| **Investing Cash Flow** | $18.21M | $23.34M | $13.96M | -$54.59M | -$11K | $40.10M | -$8.66M | -$31.59M | -- |
| Common Stock Issued | $26.69M | $1.03M | $433K | $89.64M | $32.20M | -- | -- | -- | -- |
| **Financing Cash Flow** | $26.69M | $1.03M | -$1.82M | $83.13M | $64.47M | $2.06M | $122.2M | $45.87M | $20.85M |
| **Net Change in Cash** | $18.05M | -$15.02M | -$6.38M | $12.69M | $9.93M | -$39.78M | $36.19M | -$16.32M | $9.55M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$8.98M | -$6.51M | -$4.89M | -$6.58M | -$6.09M | -$5.00M | -$7.10M | -$12.36M |
| Depreciation & Amortization | $355K | $351K | $349K | $261K | $8.0K | $8.0K | $7.0K | $440K |
| Stock-Based Compensation | $53K | $56K | $61K | $89K | $68K | $68K | $138K | $139K |
| Change in Inventory | -$201K | -$415K | -$533K | -- | -- | -- | -- | -- |
| Change in Payables | -$612K | $777K | $161K | -$584K | $14K | -$2.14M | -$2.03M | -$518K |
| **Operating Cash Flow** | -$7.45M | -$4.75M | -$3.06M | -$4.26M | -$2.67M | -$6.76M | -$13.08M | -$12.84M |
| Capital Expenditure | -$12K | $0 | -$2.0K | -- | -- | -- | -- | -- |
| **Free Cash Flow** | -$7.46M | -$4.75M | -$3.06M | -- | -- | -- | -- | -- |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | -$5.90M | -$6.49M | -$5.18M |
| **Investing Cash Flow** | -$12K | $0 | -$2.0K | $1.10M | $5.70M | $4.20M | $7.21M | $13.52M |
| Common Stock Issued | $5.43M | $5.12M | $6.36M | $13.88M | $5.43M | $167K | $7.22M | $589K |
| **Financing Cash Flow** | $5.43M | $5.12M | -$8.39M | $13.88M | $5.43M | $167K | $7.22M | $589K |
| **Net Change in Cash** | -$2.03M | $374K | -$11.47M | $10.72M | $8.43M | -$2.41M | $1.32M | $1.25M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -275732.4% | -8810.0% | -5798.2% | -- |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -278729.7% | -8867.2% | -5788.6% | -- |
| Return on Equity (ROE) | -- | -- | -158.7% | -182.3% | -- | -- | -107.6% | -74.5% | -- |
| Return on Assets (ROA) | -55.6% | -146.1% | -66.5% | -100.1% | -158.6% | -400.5% | -78.7% | -62.9% | -- |
| Current Ratio | 1.41x | 1.89x | 6.89x | 6.43x | 0.51x | 0.32x | 7.61x | 6.20x | -- |
| Quick Ratio | 1.41x | 1.89x | 6.89x | 6.43x | 0.51x | 0.32x | 7.61x | 6.20x | -- |
| Debt to Equity | -- | -- | 0.42x | 0.25x | -- | -- | 0.20x | 0.00x | -- |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -100.0% | -95.7% | +71.1% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -82.9% | -70.8% | -68.4% | -55.6% | -191.9% | -199.9% | -181.3% | -146.1% |
| Current Ratio | 2.13x | 2.69x | 3.72x | 1.41x | 0.85x | 0.82x | 1.07x | 1.89x |
| Quick Ratio | 1.96x | 2.52x | 3.58x | 1.41x | 0.78x | 0.70x | 1.02x | 1.89x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
